Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.14712/fb2020066030086 http://scihub22266oqcxt.onion/10.14712/fb2020066030086 33069187!?!33069187 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33069187&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Folia+Biol+(Praha) 2020 ; 66 (3): 86-90 Nephropedia Template TP {{tp|p=33069187|t=2020. Transfer Factor as an Option for Managing the COVID-19 Pandemic |pdf=|usr=}}{{33069187}} gab.com Text Transfer Factor as an Option for Managing the COVID-19 Pandemic JO: Folia Biol (Praha) http://www.kidney.de/pget.php?&tw=1&pmid=33069187 #FOAvip Covid-19 or SARS-CoV-2, a new RNA virus with high infectivity, and seemingly low mutability, which appeared in 2019 in the Wuhan province of China, has created a pandemic with dire consequences. At the end of May 2020, it became the first cause of mortality. As no treatment or vaccine may become available before many months, and because occurrence of similar pandemics is only a matter of time, arguments are presented here for testing the effect of transfer factor (TF), an immunomodulator devoid of toxicity, which has been extensively studied in the past for the treatment and prevention of viral infections. Twit Text FOAVip Transfer Factor as an Option for Managing the COVID-19 Pandemic ????Folia Biol (Praha) http://www.kidney.de/pget.php?&tw=1&pmid=33069187 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33069187 #FOAvip English Wikipedia <ref>{{Cite pmid|33069187}}</ref> Transfer Factor as an Option for Managing the COVID-19 Pandemic #MMPMID33069187 Viza D; Pizza G; De Vinci C; Brandi G; Ablashi D Folia Biol (Praha) 2020[]; 66 (3): 86-90 PMID33069187show ga Covid-19 or SARS-CoV-2, a new RNA virus with high infectivity, and seemingly low mutability, which appeared in 2019 in the Wuhan province of China, has created a pandemic with dire consequences. At the end of May 2020, it became the first cause of mortality. As no treatment or vaccine may become available before many months, and because occurrence of similar pandemics is only a matter of time, arguments are presented here for testing the effect of transfer factor (TF), an immunomodulator devoid of toxicity, which has been extensively studied in the past for the treatment and prevention of viral infections. |Adjuvants, Immunologic/therapeutic use[MESH] |Animals[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*immunology/*therapy[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*immunology/*therapy[MESH] |Research Design[MESH] |SARS-CoV-2[MESH]Transfer Factor as an Option for Managing the COVID-19 Pandemic (epmc).pdf DeepDyve Pubget Overpricing